Efficacy and Safety of Crizotinib among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients

由 Cao, Yabing, Xiao, Guangli, Qiu, Xibin, Ye, Sheng, Lin, Tongyu
發表在 PLoS One (2014)

Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives

由 Lang, Jinyi, Hu, Chaosu, Lu, Taixiang, Pan, Jianji, Lin, Tongyu
發表在 Cancer Manag Res (2019)

Effectiveness and safety of osimertinib in patients with metastatic EGFR T790M-positive NSCLC: An observational real-world study

由 Cao, Yabing, Qiu, Xibin, Xiao, Guangli, Hu, Hao, Lin, Tongyu
發表在 PLoS One (2019)

Primary pulmonary non‐Hodgkin's lymphoma: A retrospective analysis of 29 cases in a Chinese population

由 Huang, Jiajia, Lin, Tongyu, Li, Zhi‐Ming, Xu, Ruihua, Huang, Huiqiang, Jiang, Wenqi
發表在 Am J Hematol (2010)

Cancer Stem Cells, Endothelial Progenitors, and Mesenchymal Stem Cells: “Seed and Soil” Theory Revisited

由 Lin, Edward H., Jiang, Yixing, Deng, Yanhong, Lapsiwala, Ritu, Lin, Tongyu, Blau, C. Anthony
出版 2008

13-Methyltetradecanoic Acid Exhibits Anti-Tumor Activity on T-Cell Lymphomas In Vitro and In Vivo by Down-Regulating p-AKT and Activating Caspase-3

由 Cai, Qingqing, Huang, Huiqiang, Qian, Dong, Chen, Kailin, Luo, Junhua, Tian, Ying, Lin, Tianxin, Lin, Tongyu
出版 2013

A pharmacokinetic and safety study of single dose intravenous combretastatin A4 phosphate in Chinese patients with refractory solid tumours

由 He, Xuexin, Li, Su, Huang, He, Li, Zhiming, Chen, Likun, Ye, Sheng, Huang, Jiajia, Zhan, Jing, Lin, Tongyu
出版 2011

Outcome of R-CHOP or CHOP Regimen for Germinal Center and Nongerminal Center Subtypes of Diffuse Large B-Cell Lymphoma of Chinese Patients

由 Huang, Ying, Ye, Sheng, Cao, Yabing, Li, Zhiming, Huang, Jiajia, Huang, He, Cai, Muyan, Luo, Rongzhen, Lin, Tongyu
出版 2012

Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma

由 Cao, Yabing, Chan, Kin Iong, Xiao, Gungli, Chen, Yanqun, Qiu, Xibin, Hao, Hu, Mak, Sao Chi, Lin, Tongyu
發表在 BMC Cancer (2019)

A New Immunological Prognostic Model Based on Immunohistochemistry for Extranodal Natural Killer/T-Cell Lymphoma Patients After Non-Anthracycline-Based Chemotherapy

由 Lam, Sio Teng, Huang, He, Fang, Xiaojie, Wang, Zhao, Hong, Huangming, Ren, Quanguang, Tian, Ying, Lin, Suxia, Lin, Tongyu
發表在 Cancer Manag Res (2020)

Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implications

由 PU, XINGXIANG, PAN, ZHIZHONG, HUANG, YING, TIAN, YING, GUO, HONGQIANG, WU, LIN, HE, XUEXING, CHEN, XINGGUI, ZHANG, SHAODAN, LIN, TONGYU
出版 2013

High Serum Level of Soluble Programmed Death Ligand 1 is Associated With a Poor Prognosis in Hodgkin Lymphoma

由 Guo, Xiaofang, Wang, Juan, Jin, Jietian, Chen, Hao, Zhen, Zijun, Jiang, Wenqi, Lin, Tongyu, Huang, Huiqiang, Xia, Zhongjun, Sun, Xiaofei
發表在 Transl Oncol (2018)

Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed/refractory aggressive B-cell non-hodgkin lymphoma

由 Cai, Qingqing, Chen, Yiming, Zou, Dehui, Zhang, Liang, Badillo, Maria, Zhou, Shouhao, Lopez, Elyse, Jiang, Wenqi, Huang, Huiqiang, Lin, Tongyu, Romaguera, Jorge, Wang, Michael
出版 2014

A pharmacokinetic and safety study of a fixed oral dose of enzastaurin HCl in native Chinese patients with refractory solid tumors and lymphoma

由 Li, Xueying, Fang, Xiaojie, Li, Su, Zhang, Weijing, Yang, Nong, Cui, Yimin, Huang, He, Cai, Ruiqing, Lin, Xiaoting, Fu, Xiaohong, Hong, Huangming, Lin, Tongyu
發表在 Oncotarget (2016)

The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA du...

由 Cai, Qingqing, Chen, Kailin, Chen, Jie, Wu, Shaoxu, Geng, Qirong, Huang, Huiqiang, Lin, Tongyu, Jiang, Wenqi, Xia, Zhongjun, Duan, Huaxin, Rao, Huilan, Yao, Mengfei, Hu, Liyang
發表在 PLoS One (2016)

Long-Term Survival of Patients With Chemotherapy-Naïve Metastatic Nasopharyngeal Carcinoma Receiving Cetuximab Plus Docetaxel and Cisplatin Regimen

由 Zhang, Mengping, Huang, He, Li, Xueying, Huang, Ying, Chen, Chunyan, Fang, Xiaojie, Wang, Zhao, Guo, Chengcheng, Lam, Sioteng, Fu, Xiaohong, Hong, Huangming, Tian, Ying, Lu, Taixiang, Lin, Tongyu
發表在 Front Oncol (2020)

Chemotherapy Plus Radiotherapy Versus Chemotherapy Alone for Patients With Peripheral T-Cell Lymphoma, Not Otherwise Specified

由 Chen, Zegeng, Huang, He, Li, Xiaoqian, Fang, Xiaojie, Wang, Zhao, Hong, Huangming, Zhang, Zhihui, Cai, Qingqing, Li, Zhiming, Chen, Meiting, Yao, Yuyi, Pan, Fei, Chen, Limin, Lin, Tongyu
發表在 Front Oncol (2021)

Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors

由 Huang, JiaJia, Jiang, WenQi, Xu, RuiHua, Huang, HuiQiang, Lv, Yue, Xia, ZhongJun, Sun, XiaoFei, Guan, ZhongZhen, Lin, TongYu, Li, ZhiMing
出版 2010

A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma

由 Cui, Chuanliang, Mao, Lili, Chi, Zhihong, Si, Lu, Sheng, Xinan, Kong, Yan, Li, Siming, Lian, Bin, Gu, Kangsheng, Tao, Min, Song, Xin, Lin, Tongyu, Ren, Xiubao, Qin, Shukui, Guo, Jun
出版 2013

Outcomes of patients with peripheral T-cell lymphoma in first complete remission: data from three tertiary Asian cancer centers

由 Tang, Tiffany, Khoo, Lay Poh, Lim, Cindy, Ham, Jun Soo, Kim, Seok Jin, Hong, Huangming, Phipps, Colin, Lee, Yuh Shan, Tao, Miriam, Quek, Richard, Farid, Mohamad, Lin, Tongyu, Kim, Won Seog, Lim, Soon Thye
發表在 Blood Cancer J (2017)